Press Releases Sartorius Stedim Biotech S.A. OTC Markets

Equities

SRTOY

US80386Y1010

Market Closed - OTC Markets Other stock markets 10:14:19 2024-07-02 EDT			5-day change	1st Jan Change
15.8 ^USD	0.00%		-7.01%	-42.40%

06-27	SARTORIUS STEDIM BIOTECH : Gets a Neutral rating from Barclays	ZD
06-27	The same old winners

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL	07-02	PU
Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech	07-02	EQ
Sartorius Stedim Biotech Capital Markets: Links to presentation and webcast	05-17	EQ
Sartorius Stedim Biotech publishes unaudited first quarter results for 2024	04-18	EQ
Resolutions of the Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.	03-26	EQ
Sartorius Stedim Biotech SA: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them	02-16	EQ
Sartorius Stedim Biotech releases Universal Registration Document 2023	02-16	EQ
Sartorius Stedim Biotech: Information on Document Availability	02-16	EQ
Board of Directors of Sartorius Stedim Biotech resolves to propose a dividend of 0.69 euros per share to the Annual Shareholders’ Meeting	02-07	EQ
Sartorius Stedim Biotech SA: Sartorius Stedim Biotech S.A. successfully completes a EUR 1.2 billion share capital increase without shareholders’ preferential subscription rights	02-06	EQ
Sartorius Stedim Biotech S.A. announces an offering of approximately 1.2 billion euros of new shares without shareholders’ preferential subscription rights by means of an accelerated bookbuilding	02-06	EQ
Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2023 and provides 2024 guidance as well as new midterm outlook	01-26	EQ
Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech	01-05	EQ
Sartorius Stedim Biotech : Document AMF CP. 2023E938713	11-17	PU
Sartorius Stedim Biotech : Document AMF CP. 2023E936560	11-06	PU
Sartorius Stedim Biotech SA: Nine-month results 2023 of Sartorius Stedim Biotech	23-10-19	EQ
Sartorius Stedim Biotech SA: Sartorius Stedim Biotech pre-announces preliminary 9-month results and lowers forecast for 2023	23-10-12	EQ
Sartorius Stedim Biotech : completes placement of bonds with a volume of 3 billion euro...	23-09-07	PU
Sartorius Stedim Biotech : Florian Funck appointed CFO of Sartorius	23-08-03	PU
Sartorius Stedim Biotech : Conference Call H1\|2023 Presentation	23-07-21	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

SARTORIUS STEDIM BIOTECH : EPS cut (2023: -13.7%, 2024: -16.4%)

June 03, 2024 at 03:32 am